differential effects of jak1 vs. jak2 inhibition in mouse models of hlh
Published 3 months ago • 77 plays • Length 18:40Download video MP4
Download video MP3
Similar videos
-
3:15
mechanism of action of jak inhibitors
-
19:04
my view on current and future use of jak inhibitors for et, pv, and mf
-
25:15
how to manage side effects of jak inhibitors for mylofibrosis in the clinical practice
-
4:01
the role of jak2 inhibition in patients with pv
-
3:22
jak2 inhibition in the treatment of myelofibrosis
-
13:55
role of janus kinase signaling in gvhd
-
30:13
jak inhibitors: safety of tofacitinib - alexei grom (on behalf of hermine brunner)
-
2:37
the role of jak inhibitors in reducing gvhd severity
-
28:40
an overview of selective jak inhibitors and relevance for sjia-ld - dr. massimo gadina
-
43:42
jak-inhibition in immune-mediated diseases (imids)
-
1:06:28
role of jak inhibitors in ra and psa.
-
22:51
a user's guide to jak inhibition for ibd
-
5:21
mechanism of jak inhibitors and a review of ruxolitinib
-
15:28
jak therapies: mechanism of action, pharmacotherapeutic profiles, and positioning
-
36:55
janus kinase (jak) inhibitor discontinuation clinical pearl
-
15:32
the role of jak inhibitors in your clinical practice
-
21:26
cytokine signaling are all jak inhibitors the same?
-
3:21
a phase i trial of hu8f4, an anti-pr1/hla-a2 monoclonal antibody, in r/r myeloid malignancies